United States
Print page content Print
Increase text size Decrease text size
Text Size
Simparica

Resources

Training & Promotional Tools

Simparica resources include staff training modules, clinic emails and letters, online advertising tools and social media posts. Download these resources to use for your practice.

Clinic Letters and Emails

Customizable letters and emails

These letters and emails are designed to help you reach out to pet owners to share info about Simparica. They can be customized with your practice name, address, and phone.

1. Introduction to Pet Owners
2. Simparica and Lyme
3. Simparica and ProHeart 6
4. Simparica Rebate Tear Pad

Online Advertising Tools

Facebook Posts

Twitter Posts

Banner Ads

Tell pet owners about Simparica, the once-monthly chewable that keeps going strong for 35 days1

1. 160x600 skyscraper
2. 300x250 medium rectangle
3. 728x90 leaderboard

Posters

Posters

1. Pet Owner Poster
2. Rebate Detail Poster
3. Infographic Poster

Staff Training

Flea Module

Find out why fleas can cause more harm than you may think and how Simparica provides protection that goes on and on all month long.

Tick Module

Learn how ticks can transmit diseases and how Simparica has fast-kill effectiveness that lasts all month long.

Clinical Studies

Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica) against fleas on dogs.

Efficacy of a novel oral formulation of sarolaner (Simparica) against five common tick species infesting dogs in the United States.

Evaluation of the speed of kill of sarolaner (Simparica) against induced infestations of three species of ticks (Amblyomma maculatum, Ixodes scapularis, Ixodes ricinus) on dogs.

Efficacy and safety of sarolaner (Simparica) against fleas on dogs presented as veterinary patients in the United States.

Efficacy of sarolaner in the prevention of Borrelia burgdorferi and Anaplasma phagocytophilum transmission from infected Ixodes scapularis to dogs.

Comparative speed of kill of oral treatments with Simparica(sarolaner) and Bravecto®(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs.

Comparative speed of kill of sarolaner (Simparica) and spinosad plus milbemycin oxime (Trifexis®) against induced infestations of Ctenocephalides felis on dogs.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard®) against induced infestations of Ctenocephalides felis on dogs.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard®) against induced infestations of Amblyomma americanum on dogs.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard®) against induced infestations of Rhipicephalus sanguineus s.l. on dogs.

Comparative speed of kill of sarolaner (Simparica) and fluralaner (Bravecto®) against induced infestations of Ctenocephalides felis on dogs.

Comparative speed of kill of sarolaner (Simparica) and afoxolaner (NexGard®) against induced infestations of Ixodes scapularis on dogs.

IMPORTANT SAFETY INFORMATION
Simparica is for use only in dogs, 6 months of age and older. Simparica may cause abnormal neurologic signs such as tremors, decreased conscious proprioception, ataxia, decreased or absent menace, and/or seizures. Simparica has not been evaluated in dogs that are pregnant, breeding or lactating. Simparica has been safely used in dogs treated with commonly prescribed vaccines, parasiticides and other medications. The most frequently reported adverse reactions were vomiting and diarrhea. See full Prescribing Information.


Reference:
1.  Six RH, Everett WR, Young DR, et al. Efficacy of a novel oral formulation of sarolaner (Simparica) against five common tick species infesting dogs in the United States. Vet Parasitol. 2016;222:28-32.

This site is intended for U.S. Animal Healthcare Professionals.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2017 Zoetis Services LLC. All rights reserved. SMP-00181R1